{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T05:49:59Z","timestamp":1743054599138,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":15,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642247873"},{"type":"electronic","value":"9783642247880"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-24788-0_8","type":"book-chapter","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T04:27:16Z","timestamp":1319689636000},"page":"79-90","source":"Crossref","is-referenced-by-count":0,"title":["Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon\/Ribavirin Therapy"],"prefix":"10.1007","author":[{"given":"Saori","family":"Kawasaki","sequence":"first","affiliation":[]},{"given":"Tu Bao","family":"Ho","sequence":"additional","affiliation":[]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[]},{"given":"Katsuhiro","family":"Takabayashi","sequence":"additional","affiliation":[]},{"given":"Nhan","family":"Le","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"8_CR1","unstructured":"Murray, P.R., Rosenthal, K.S., Pfaller, M.A.: Medical Microbiology, Ch. 66. Mosby Philadelphia (2009)"},{"key":"8_CR2","first-page":"953","volume":"465","author":"M. Gao","year":"2010","unstructured":"Gao, M., Nettles, R.E., et al.: Chemical genetics strategy identifies an hcv ns5a inhibitor with a potent clinical effect. Nature\u00a0465, 953\u2013960 (2010)","journal-title":"Nature"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.antiviral.2010.02.003","volume":"86","author":"S.M. Lemon","year":"2010","unstructured":"Lemon, S.M., Keating, J.A., Pietschmannc, T., Frickd, D.N., Glenne, J.S., Tellinghuisenf, T.L., Symonsg, J., Furman, P.A.: Development of novel therapies for hepatitis c. Antiviral Research\u00a086, 79\u201392 (2010)","journal-title":"Antiviral Research"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.meegid.2008.11.001","volume":"9","author":"A.C.G. Jardim","year":"2009","unstructured":"Jardim, A.C.G., Yamasaki, L.H.T., Queiro, A.T.L., Bittar, C., Rahal, R.P.R., de Carvalho Mello, I.M.V.: Quasispecies of hepatitis c virus genotype 1 and treatment outcome with peginterferon and ribavirin. Infection, Genetics and Evolution\u00a09, 689\u2013698 (2009)","journal-title":"Infection, Genetics and Evolution"},{"key":"8_CR5","first-page":"225","volume":"119","author":"R. Aurora","year":"2009","unstructured":"Aurora, R., Donlin, M.J., Cannon, N.A.: Genome-wide hepatitis c virus amino acid covariance networks can predict response to antiviral therapy in humans. The Journal of Clinical Investigation\u00a0119, 225\u2013236 (2009)","journal-title":"The Journal of Clinical Investigation"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"J.J. Feld","year":"2005","unstructured":"Feld, J.J., Hoofnagle, J.H.: Mechanism of action of interferon and ribavirin in treatment of hepatitis c. Nature\u00a0436, 967\u2013972 (2005)","journal-title":"Nature"},{"key":"8_CR7","first-page":"77","volume":"334","author":"N. Enomoto","year":"2010","unstructured":"Enomoto, N., Maekawa, S.: Hcv genetic elements determining the early response to peginterferon and ribavirin therapy. Intervirology\u00a0334, 77\u201381 (2010)","journal-title":"Intervirology"},{"key":"8_CR8","first-page":"96","volume":"436","author":"R. Francessco","year":"2005","unstructured":"Francessco, R., Migliaccio, G.: Challenges and successes in developing new therapies for hepatitis c. Nature\u00a0436, 96\u2013100 (2005)","journal-title":"Nature"},{"issue":"17","key":"8_CR9","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3748\/wjg.v13.i17.2416","volume":"13","author":"H.L. Guillou-Guillemette","year":"2007","unstructured":"Guillou-Guillemette, H.L., Vallet, S., Gaudy-Graffin, C., Payan, C., Pivert, A., Goudeau, A., Lunel-Fabiani, F.: Genetic diversity of the hepatitis c virus: Impact and issues in the antiviral therapy. World Journal of Gastroenterology\u00a013(17), 2416\u20132426 (2007)","journal-title":"World Journal of Gastroenterology"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-7-1","volume":"7","author":"M.M. AlHefnawi","year":"2010","unstructured":"AlHefnawi, M.M., Zada, S., El-Azab, I.A.: Prediction of prognostic biomarker for interferon-based therapy to hepatitis c virus patients: a metaanalysis of the ns5a protein in subtypes 1a, 1b, and 3a. Virology Journal\u00a07, 1\u20139 (2010)","journal-title":"Virology Journal"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","volume":"85","author":"A. Macdonaldt","year":"2004","unstructured":"Macdonaldt, A., Harris, M.: Hepatitis c virus ns5a: Tales of a promiscuous protein. Journal of General Virology\u00a085, 2485\u20132502 (2004)","journal-title":"Journal of General Virology"},{"key":"8_CR12","doi-asserted-by":"crossref","unstructured":"Wohnsland, A., Hofmann, W.P., Sarrazin, C.: Viral determinants of resistance to treatment in patients with hepatitis c. Clinical Microbiology Reviews, 20 (2007)","DOI":"10.1128\/CMR.00010-06"},{"key":"8_CR13","first-page":"17","volume":"131","author":"S.D. Sharma","year":"2010","unstructured":"Sharma, S.D.: Hepatitis c virus: Molecular biology & current therapetic options. Indian Journal of Medical Research\u00a0131, 17\u201334 (2010)","journal-title":"Indian Journal of Medical Research"},{"issue":"5","key":"8_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","volume":"103","author":"S.M. Kamal","year":"2008","unstructured":"Kamal, S.M.: Acute hepatitis c: a systematic review. The American Journal of Gastroenterology\u00a0103(5), 1283\u20131297 (2008)","journal-title":"The American Journal of Gastroenterology"},{"issue":"3","key":"8_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/bioinformatics\/bth485","volume":"21","author":"C. Kuiken","year":"2005","unstructured":"Kuiken, C., Yusim, K., Boykin, L., Richardson, R.: The los alamos hepatitis c sequence database. Bioinformatics\u00a021(3), 379\u2013384 (2005)","journal-title":"Bioinformatics"}],"container-title":["Lecture Notes in Computer Science","Knowledge, Information, and Creativity Support Systems"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-24788-0_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T04:11:00Z","timestamp":1555215060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-24788-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642247873","9783642247880"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-24788-0_8","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2011]]}}}